Sam Fuld Biography
Claim to Fame: Outfielder, Tampa Bay Rays
DOB: November 20th, 1981
Diabetes Type: 1
Born in Durham, New Hampshire, Sam Fuld currently plays for the Tampa Bay Rays as an outfielder in Major League Baseball. Having managed his diabetes since his childhood, Fuld has led an active and impressive career in baseball.
Diagnosed with type 1 diabetes at age 10, Fuld has experienced the difficulties of diabetes for nearly his entire life. At age 12, Fuld met Bill Gullickson, a pitcher with diabetes who inspired him to strive for a career in baseball despite his illness. By high school, Fuld had twice batted .600 and was ranked 19th in the country by Baseball America. Playing college baseball at Stanford, Fuld set the school record for career runs scored and the College World Series record for career hits scored.
By 2004, Fuld was drafted by the Chicago Cubs and won the title of All Star in the Florida State League within two years. He made his official debut for the Cubs in 2007 and was soon nicknamed "Super Sam" for his aggressive defense and energetic catching. In 2010, he was traded to the Tampa Bay Rays.
Fuld manages his diabetes by constantly checking his blood sugar and takes as many as five insulin shots a day. He enthusiastically advocates the benefits of physical activity in the management of diabetes, and encourages children to not let diabetes hold them back from participating in sports. In partnership with the USF Diabetes Center and the Florida Diabetes camp, Fuld helped organize a sports camp for type 1 children in February of 2012. As a member of the diabetes community, Fuld continues to inspire both type 1 children and adults with his outstanding performance in baseball.
Fruity Bran Bread Seitan Roast with Mushroom Gravy Sun-Dried Tomato Avocado Salsa Apricot Tea Mexican Ceviche English Muffin Breakfast Pizza Carrot Pudding Chicken Breast Stuffed with Spinach and Cheese Prosciutto Wrapped Olives Cinnamon-Cheese-Almond Muffins
If you listen closely, you may hear the sound of 25 million Americans with diabetes rejoicing today. In a revolutionary movement, the FDA has given 510(k) approval on Abbott's HbA1C test which is expected to help millions of Americans with Type 1 or 2 diabetes or those at risk. Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1C (HbA1C) test is a dramatic shift in diabetes diagnosis and monitoring. Instead of the HbA1C tests performed at a laboratory and constituted as blood work, the...